BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 29335545)

  • 1. An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.
    Chen M; Zhang J; Sampieri K; Clohessy JG; Mendez L; Gonzalez-Billalabeitia E; Liu XS; Lee YR; Fung J; Katon JM; Menon AV; Webster KA; Ng C; Palumbieri MD; Diolombi MS; Breitkopf SB; Teruya-Feldstein J; Signoretti S; Bronson RT; Asara JM; Castillo-Martin M; Cordon-Cardo C; Pandolfi PP
    Nat Genet; 2018 Feb; 50(2):206-218. PubMed ID: 29335545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
    Li X; Wu JB; Chung LW; Huang WC
    Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
    Tan M; Xu J; Siddiqui J; Feng F; Sun Y
    Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A basal-enriched microRNA is required for prostate tumorigenesis in a Pten knockout mouse model.
    Fan X; Bjerke GA; Riemondy K; Wang L; Yi R
    Mol Carcinog; 2019 Dec; 58(12):2241-2253. PubMed ID: 31512783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
    Manda KR; Tripathi P; Hsi AC; Ning J; Ruzinova MB; Liapis H; Bailey M; Zhang H; Maher CA; Humphrey PA; Andriole GL; Ding L; You Z; Chen F
    Oncogene; 2016 Jun; 35(25):3282-92. PubMed ID: 26477312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
    Kwon OJ; Zhang L; Wang J; Su Q; Feng Q; Zhang XH; Mani SA; Paulter R; Creighton CJ; Ittmann MM; Xin L
    J Clin Invest; 2016 Jul; 126(7):2626-41. PubMed ID: 27294523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
    Ding Z; Wu CJ; Chu GC; Xiao Y; Ho D; Zhang J; Perry SR; Labrot ES; Wu X; Lis R; Hoshida Y; Hiller D; Hu B; Jiang S; Zheng H; Stegh AH; Scott KL; Signoretti S; Bardeesy N; Wang YA; Hill DE; Golub TR; Stampfer MJ; Wong WH; Loda M; Mucci L; Chin L; DePinho RA
    Nature; 2011 Feb; 470(7333):269-73. PubMed ID: 21289624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.
    Jiao J; Wang S; Qiao R; Vivanco I; Watson PA; Sawyers CL; Wu H
    Cancer Res; 2007 Jul; 67(13):6083-91. PubMed ID: 17616663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
    Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
    Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer.
    Hubbard GK; Mutton LN; Khalili M; McMullin RP; Hicks JL; Bianchi-Frias D; Horn LA; Kulac I; Moubarek MS; Nelson PS; Yegnasubramanian S; De Marzo AM; Bieberich CJ
    Cancer Res; 2016 Jan; 76(2):283-92. PubMed ID: 26554830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid in vivo validation of candidate drivers derived from the PTEN-mutant prostate metastasis genome.
    Cho H; Herzka T; Stahlhut C; Watrud K; Robinson BD; Trotman LC
    Methods; 2015 May; 77-78():197-204. PubMed ID: 25592467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer.
    Alioui A; Dufour J; Leoni V; Loregger A; Moeton M; Iuliano L; Zerbinati C; Septier A; Val P; Fouache A; Russo V; Volle DH; Lobaccaro JA; Zelcer N; Baron S
    Nat Commun; 2017 Sep; 8(1):445. PubMed ID: 28874658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
    Li N; Xue W; Yuan H; Dong B; Ding Y; Liu Y; Jiang M; Kan S; Sun T; Ren J; Pan Q; Li X; Zhang P; Hu G; Wang Y; Wang X; Li Q; Qin J
    J Clin Invest; 2017 Apr; 127(4):1284-1302. PubMed ID: 28319045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SREBP-2 promotes stem cell-like properties and metastasis by transcriptional activation of c-Myc in prostate cancer.
    Li X; Wu JB; Li Q; Shigemura K; Chung LW; Huang WC
    Oncotarget; 2016 Mar; 7(11):12869-84. PubMed ID: 26883200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis.
    Chen Z; Trotman LC; Shaffer D; Lin HK; Dotan ZA; Niki M; Koutcher JA; Scher HI; Ludwig T; Gerald W; Cordon-Cardo C; Pandolfi PP
    Nature; 2005 Aug; 436(7051):725-30. PubMed ID: 16079851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model.
    Wang Z; Xu D; Ding HF; Kim J; Zhang J; Hai T; Yan C
    Oncogene; 2015 Sep; 34(38):4975-84. PubMed ID: 25531328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of CHK1 by ETS Family Members Promotes DNA Damage Response Bypass and Tumorigenesis.
    Lunardi A; Varmeh S; Chen M; Taulli R; Guarnerio J; Ala U; Seitzer N; Ishikawa T; Carver BS; Hobbs RM; Quarantotti V; Ng C; Berger AH; Nardella C; Poliseno L; Montironi R; Castillo-Martin M; Cordon-Cardo C; Signoretti S; Pandolfi PP
    Cancer Discov; 2015 May; 5(5):550-63. PubMed ID: 25653093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen regulation of prostasin gene expression is mediated by sterol-regulatory element-binding proteins and SLUG.
    Chen M; Chen LM; Chai KX
    Prostate; 2006 Jun; 66(9):911-20. PubMed ID: 16541421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLUG is a direct transcriptional repressor of PTEN tumor suppressor.
    Uygur B; Abramo K; Leikina E; Vary C; Liaw L; Wu WS
    Prostate; 2015 Jun; 75(9):907-16. PubMed ID: 25728608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis.
    Wu Z; Cho H; Hampton GM; Theodorescu D
    Neoplasia; 2009 Jan; 11(1):66-76. PubMed ID: 19107233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.